title: [Diagnosis and therapy of 186 spontaneous bacterial peritonitis patients with end-stage liver disease].
abstract: OBJECTIVE
  To improve the diagnosis and treatment level of spontaneous bacterial peritonitis (SBP) in the patients with advanced liver disease, get better curative effect and prognosis.
  
  
  METHODS
  Registered the body temperature, symptoms and signs in the abdomen, and blood routine test, the polymorphonuclear (PMN) cell count, and ascites culture in the patients with cirrhosis and fulminant hepatitis. These patients were given supporting therapies including use plasma and albumin as well as antibiotics treatment according to drug sensitivity or empiric. Changes of the body temperature, symptoms and signs were used to evaluate the effect of therapy.
  
  
  RESULTS
  186 of 275 inward patients with end-stage liver disease during this period were considered as SBP by ascites culture or clinical experience with various degree symptoms and signs such as pain, distention, higher tension and touch pain in the abdomen. Infective rate was 67.6%. Among them 138 patients had abnormal body temperature more than 37.4 degrees C. 106 patients with leukocyte count in the peripheral blood more than 10 x 10(9)/L; 137 patients with PMN more than 80% in differential cell count; 103 patients with PMN more than 250/mm(3) in ascites. Only 29 patients were culture positive. 82 patients were cured, 17 patients with improvement, 18 patients with inefficacy or deterioration. 42 patients died of hepatic-renal failure and 27 patients died because of upper alimentary tract bleeding, respectively.
  
  
  CONCLUSIONS
  Signs and symptoms of SBP were atypical in the patients with end-stage liver disease. Ascites culture positive rate was not high. Early diagnosis and proper use antibiotics according to culture and empirics were important to increase effect and improve prognosis
authors.affiliation: Department of Infectious Diseases, the Second Affiliated Hospital of Chongqing University of Medical Sciences, Chongqing 400010, China.
authors.forename: Zhi
authors.initials: Z
authors.lastname: Zhou
authors.forename: Ning
authors.initials: N
authors.lastname: Lai
authors.forename: Quan-hai
authors.initials: QH
authors.lastname: Zhang
authors.forename: Yuan
authors.initials: Y
authors.lastname: Guo
authors.forename: Chang-wu
authors.initials: CW
authors.lastname: Huang
authors.forename: Da-zhi
authors.initials: DZ
authors.lastname: Zhang
authors.forename: Hong
authors.initials: H
authors.lastname: Ren
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000175:diagnosis / Q000382:microbiology* / Q000628:therapy; D005260:Female; D006801:Humans; D008107:Liver Diseases / Q000150:complications*; D008297:Male; D008875:Middle Aged; D010538:Peritonitis / Q000175:diagnosis / Q000382:microbiology* / Q000628:therapy; D011379:Prognosis
chemical_list: D000900:Anti-Bacterial Agents